Simon Karger
With over 20 years of experience in cutting edge medical device and platform development, my current focus is in bringing the transformative potential of AI to medical and healthcare biotech applications. At Cambridge Consultants (the deep tech powerhouse of CapGemini) I work with the industry's most ambitious companies to explore how AI can integrate into their BioEngineering processes, medical products and sensor rich platforms to deliver the therapies, devices and pharmaceuticals of tomorrow. From cutting edge lab-in-the-loop automation for optimised enzyme development to next generation genomic therapies and even AI powered surgical robotics, we unlock top line growth and sustainable competitive advantage for our clients through the deployment of AI in the products of the future.
Cambridge Consultants
Assessing Progress in AI for Protein Engineering: Where Are We Now, and Where Are We Going?
-
Protein engineering is the most active frontier for AI in biotech. We are seeing the emergence of models that can make "zero shot" predictions of antibodies, and new variants of enzymes that would take millions of years for Evolution to produce. How should we be evaluating these models and their designs? What can we expect from the field of AI protein design moving forward?
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
